Integer (ITGR) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Integer (ITGR) has outperformed TransMedics Group (TMDX) over the past year, gaining 20.2% versus a loss of 33.1%. Over five years, TMDX leads with a +197.6% price change compared with +41.9% for ITGR. Integer is the larger company by market cap ($4.31 billion vs $2.74 billion), about 1.6 times the size, while TransMedics Group is growing revenue faster (+37.1% vs +8.0%).
On valuation, Integer trades at a lower forward P/E (18.4x vs 35.0x for TransMedics Group). TransMedics Group converts more of its revenue into profit, with a net margin of 31.4% versus 5.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITGR | TMDX |
|---|---|---|
| Share price | $126.65 | $79.00 |
| Market cap | $4.31B | $2.74B |
| 1-day change | +0.05% | -2.55% |
| YTD return | +61.48% | -35.06% |
| 1-year return | +20.21% | -33.08% |
| 5-year return | +41.86% | +197.55% |
| P/E ratio (TTM) | 34.60 | 20.47 |
| Forward P/E | 18.44 | 35.05 |
| EPS (TTM) | $3.66 | $3.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.85B | $605.49M |
| Revenue growth (YoY) | +7.98% | +37.13% |
| Net income (latest FY) | $102.81M | $190.29M |
| Gross margin | 26.99% | 59.92% |
| Operating margin | 11.94% | 17.93% |
| Net margin | 5.55% | 31.43% |
| 52-week high | $126.80 | $156.00 |
| 52-week low | $62.00 | $60.11 |
| Distance from 52-week high | -0.12% | -49.36% |
| Analyst consensus | none | buy |
| Avg. price target upside | -3.83% | +26.35% |
| Average volume | 981.56K | 820.41K |
| Shares outstanding | 34.00M | 34.68M |
| Employees | 11,000 | 898 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ITGR has outperformed TMDX by 53.3 percentage points over the past year.
- Integer trades at a higher earnings multiple (34.6x vs 20.5x trailing P/E).
- TransMedics Group is more profitable, keeping 31.4 cents of every revenue dollar as net income versus 5.5 cents for Integer.
- TransMedics Group grew revenue faster in its latest fiscal year (+37.13% vs +7.98%).
About Integer
ITGR stock →Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 898 employees
ITGR vs TMDX FAQ
Which is bigger, Integer or TransMedics Group?
Integer (ITGR) is larger, with a market capitalization of $4.31B compared with $2.74B for TransMedics Group (TMDX).
Which stock has performed better over the past year, ITGR or TMDX?
ITGR returned +20.21% over the past 12 months, compared with -33.08% for TMDX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ITGR or TMDX?
TMDX has the lower trailing P/E at 20.5, versus 34.6 for ITGR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Integer and TransMedics Group in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.